NST-1024
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NST-1024, covering 2024-03-08 to 2025-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia [Phase 2]